Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage

Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-99
SponsorChristian Medical College and Hospital, Ludhiana, India

About this trial

BEAT ICH will be a pragmatic, randomised, placebo-controlled, blinded, superiority clinical trial aiming to recruit 5676 patients aged ≥18 years who survive ICH and assign them 1:1 to starting antiplatelet monotherapy (Aspirin 75 mg od) versus placebo for the entire duration of the trial for preventing MACE. Recruitment duration is for 2.5 years. The duration of the medication and follow-up will vary based on recruitment timeline. If recruited during the first year of the trial, the patient will take the medication for three years or until the trial ends or an event occurs, with a matching follow-up period. If recruited towards the end of the trial, he/she will take the medication for six months and be followed up for the same duration. The trial's follow-up duration is three years. The patients will be recruited for 2.5 years, and the last recruit will have a minimum follow-up of six months. No new patients will be recruited within the last six months of the trial, but all the patients will be followed up until the end of the trial.

Eligibility criteria

Qualifiers

Age ≥18 years

First-ever Intracerebral Haemorrhage

Presenting ≥24 hrs up to 3 months of stroke symptoms confirmed by brain imaging

CT /MRI confirming Intracerebral Haemorrhage

Disqualifiers

ICH is known to be due to trauma, a structural cause (e.g., aneurysm, arteriovenous malformation, cerebral cavernous malformation, venous thrombosis, or tumour), or haemorrhagic transformation of cerebral infarction

Glasgow coma score ≤5

Taking any antiplatelet or anticoagulant therapy 15 days prior to randomization.

Women pregnant, breastfeeding, childbearing potential, and not using contraceptives

Trial design

Treatments tested in this trial

  • Aspirin 75 mg daily
  • Placebo

Treatment groups

5,676 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Christian Medical College and Hospital, Ludhiana, India

Lead sponsor

Indian Council of Medical Research

Collaborator

St. Stephen's Hospital, Delhi

Collaborator

Amrita Institute of Medical Sciences & Research Center

Collaborator

Kasturba Medical College

Collaborator

Bangur Institute of Neurosciences Kolkata

Collaborator

Baptist Christian Hospital, Tezpur, India

Collaborator

Christian Medical College, Vellore, India

Collaborator

Lalitha Super Specialities Hospital

Collaborator

Dr. Ramesh Cardiac and Multispecialty Hospital Guntur, India

Collaborator

Government General Hospital Guntur, India

Collaborator

Institute of Medical Sciences of the Banaras Hindu University, India

Collaborator

All India Institute of Medical Sciences, Bhubaneswar

Collaborator

KLE'S Dr Prabhakar Kore Hospital & MRC Balgaum

Collaborator

Guru Gobind Singh Medical College & Hospital

Collaborator

PBM Hospital Bikaner, India

Collaborator

Excelcare Hospitals Guwahati

Collaborator

Bharati Vidyapeeth DTU Medical College Pune, India

Collaborator

All India Institute of Medical Sciences, Bilaspur

Collaborator

KG Hospital and Post Graduate Medical Institute Coimbatore, India

Collaborator

Tirunelveli Medical College, Tirunelveli, India

Collaborator

Santokba Durlabhji Memorial Hospital

Collaborator

Institute of Human Behaviour and Allied Sciences Delhi

Collaborator

Government Medical College Trivandrum, India

Collaborator

Jaiswal Multispeciality Hospital And Neuro Institute, Kota

Collaborator

Shri Maharaja Hari Singh Hospital

Collaborator

Government Medical College, Anantnag, India

Collaborator

Narayana Medical College & Hospital

Collaborator

Renova Institute of Neurological Sciences (RINS); Renova Century Hospital Hyderabad

Collaborator

Rangaraya Medical College

Collaborator

All India Institute of Medical Sciences, Raebareli, UP

Collaborator

All India Institute of Medical Science, Patna, Bihar, India

Collaborator

Sri Balaji Institute of Medical Sciences, Raipur, Chhattisgarh, India

Collaborator

Manipal Group of Hospitals (Eastern Region), Kolkata, India

Collaborator

Sree Chitra Tirunal Institute for Medical Sciences & Technology

Collaborator

All India Institute of Medical Science, Guwahati

Collaborator

All India Institute of Medical Science, New Delhi

Collaborator

King George's Medical University, Lucknow, India

Collaborator

P. D. Hinduja Hospital and Medical Research Centre

Collaborator

KIMS-SUNSHINE Hospital, Hyderabad, India

Collaborator

Sahyadri Superspeciality Hospital, Nasik

Collaborator

Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India

Collaborator